On April 28, 2025, Petros Pharmaceuticals, Inc. filed a notice of delisting appeal with Nasdaq due to public interest concerns about a recent securities offering. Additionally, a 1-for-25 reverse stock split will be effective starting April 30, 2025, altering share counts without changing overall value.